drugset / Trial / NCT02184299

Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients

NCT02184299

Phase 4 Completed 138 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

Study to determine the incidence of rash between the group receiving nevirapine without prednisone and the group receiving nevirapine with prednisone

Timeline

Start
1999-04
Primary completion
2000-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule
Subject Prednisone Other / unclassified